Jaguar Health (JAGX) Cash from Investing Activities (2016 - 2025)
Jaguar Health (JAGX) has disclosed Cash from Investing Activities for 9 consecutive years, with $13000.0 as the latest value for Q4 2025.
- Quarterly Cash from Investing Activities rose 106.05% to $13000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$202000.0 through Dec 2025, up 6.05% year-over-year, with the annual reading at -$41000.0 for FY2025, 82.25% up from the prior year.
- Cash from Investing Activities for Q4 2025 was $13000.0 at Jaguar Health, up from -$215000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $10.5 million in Q4 2021, with the low at -$10.5 million in Q3 2021.
- Average Cash from Investing Activities over 4 years is -$103166.7, with a median of -$135500.0 recorded in 2022.
- The sharpest move saw Cash from Investing Activities tumbled 103.45% in 2022, then surged 106.05% in 2025.
- Over 4 years, Cash from Investing Activities stood at $10.5 million in 2021, then crashed by 103.45% to -$361000.0 in 2022, then skyrocketed by 40.44% to -$215000.0 in 2024, then soared by 106.05% to $13000.0 in 2025.
- According to Business Quant data, Cash from Investing Activities over the past three periods came in at $13000.0, -$215000.0, and -$361000.0 for Q4 2025, Q4 2024, and Q4 2022 respectively.